After a five-year contraction in employer healthcare spending growth, medical inflation in the United States is projected to rise to 6.8% in 2015, according to PricewaterhouseCoopers’ Health Research Institute.
America’s biopharmaceutical research companies are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population, according to a new report released by the Pharmaceutical Research and Manufacturers of America last week.
The Food and Drug Administration has published a draft guidance document for prescription drug supply chain stakeholders as part of the agency’s implementation of the Drug Supply Chain Security Act, the National Association of Boards of Pharmacy has reported.
Novo Nordisk on Thursday announced the launch of Levemir FlexTouch (insulin detemir [rDNA origin] injection), a prefilled insulin delivery mechanism, providing a new way for diabetics to administer their insulin.
The American Association of Colleges of Pharmacy has invited George Allen, associate professor in the department of pharmacy practice at the University of New England College of Pharmacy, to participate in its 2014-15 AACP Academic Leadership Fellows Program.
Canada’s Federal Court ruled recently that the country’s Patented Medicine Prices Review Board — a federal tribunal that regulates pricing on branded medicines — could not extend price-control measures to cover generic drug companies, according to published reports.
As patients across North America continue to turn to their neighborhood pharmacy for vaccinations, state and provincial governments in the United States and Canada are widening the range of immunizations that can be administered by a pharmacist.
A survey co-released on Wednesday by the Generic Pharmaceutical Association and the National Coalition on Healthcare reveals that the healthcare providers patients rely on most to explain safety information about their prescription drugs have serious concerns about a proposed FDA rule on generic drug labeling.
A survey co-released Wednesday by the Generic Pharmaceutical Association and the National Coalition on Healthcare reveals that 8-in-10 healthcare providers have serious concerns about a proposed Food and Drug Administration rule on generic drug labeling.
Walgreens and Arizona Priority Care have announced a clinical care collaboration agreement to provide coordinated, expanded services for AzPC Medicare Advantage and ACO members through select Walgreens pharmacies and Healthcare Clinics.
The Hamacher Resource Group has announced that Dave Wendland, VP and member of the owners group at Hamacher Resource Group, will be speaking to members of the American Society for Automation in Pharmacy June 27 at their 2014 Midyear conference in Palm Beach, Fla., and on July 21, will speak to independent pharmacists attending McKesson’s IdeaShare conference in Orlando, Fla.